Health technology assessment of fostimon, a highly purified human-derived urofollitropin for the treatment of infertility

Chiara Cadeddu; Maria Lucia Specchia; Chiara De Waure; Francesco Di Nardo; Silvio Capizzi; S Capri; Gualano; N Nicolotti; F Kheiraoui; A Sferrazza; Agostino Mancuso; G Avallone; G La Torre; Walter Ricciardi

Health technology assessment of fostimon, a highly purified human-derived urofollitropin for the treatment of infertility

Chiara Cadeddu
, Maria Lucia Specchia
, Chiara De Waure
, Francesco Di Nardo
, Silvio Capizzi
, S Capri
, Gualano
, N Nicolotti
, F Kheiraoui
, A Sferrazza
, Agostino Mancuso
, G Avallone
, G La Torre
, Walter Ricciardi

Risultato della ricerca: Contributo in libro › Contributo a conferenza

Abstract

Nessuno

Lingua originale	Inglese
Titolo della pubblicazione ospite	Proceedings of 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”
Pagine	107
Numero di pagine	1
Stato di pubblicazione	Pubblicato - 2013
Evento	10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?” - Seoul Durata: 15 giu 2013 → 19 giu 2013

Convegno

Convegno	10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”
Città	Seoul
Periodo	15/6/13 → 19/6/13

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

Health Technology Assessment
Human-derived Urofollitropin
Infertility

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Cadeddu, C., Specchia, M. L., De Waure, C., Di Nardo, F., Capizzi, S., Capri, S., Gualano, Nicolotti, N., Kheiraoui, F., Sferrazza, A., Mancuso, A., Avallone, G., La Torre, G., & Ricciardi, W. (2013). Health technology assessment of fostimon, a highly purified human-derived urofollitropin for the treatment of infertility. In Proceedings of 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?” (pagg. 107)

@inproceedings{7cf0702f931845f6b91782285627e02b,

title = "Health technology assessment of fostimon, a highly purified human-derived urofollitropin for the treatment of infertility",

abstract = "Nessuno",

keywords = "Health Technology Assessment, Human-derived Urofollitropin, Infertility, Health Technology Assessment, Human-derived Urofollitropin, Infertility",

author = "Chiara Cadeddu and Specchia, \{Maria Lucia\} and \{De Waure\}, Chiara and \{Di Nardo\}, Francesco and Silvio Capizzi and S Capri and Gualano and N Nicolotti and F Kheiraoui and A Sferrazza and Agostino Mancuso and G Avallone and \{La Torre\}, G and Walter Ricciardi",

year = "2013",

language = "English",

isbn = "Nessuno",

pages = "107",

booktitle = "Proceedings of 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”",

note = "10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?” ; Conference date: 15-06-2013 Through 19-06-2013",

}

Cadeddu, C, Specchia, ML, De Waure, C, Di Nardo, F, Capizzi, S, Capri, S, Gualano, Nicolotti, N, Kheiraoui, F, Sferrazza, A, Mancuso, A, Avallone, G, La Torre, G & Ricciardi, W 2013, Health technology assessment of fostimon, a highly purified human-derived urofollitropin for the treatment of infertility. in Proceedings of 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”. pagg. 107, 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”, Seoul, 15/6/13.

Health technology assessment of fostimon, a highly purified human-derived urofollitropin for the treatment of infertility. / Cadeddu, Chiara; Specchia, Maria Lucia; De Waure, Chiara et al.
Proceedings of 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”. 2013. pag. 107.

Risultato della ricerca: Contributo in libro › Contributo a conferenza

TY - GEN

T1 - Health technology assessment of fostimon, a highly purified human-derived urofollitropin for the treatment of infertility

AU - Cadeddu, Chiara

AU - Specchia, Maria Lucia

AU - De Waure, Chiara

AU - Di Nardo, Francesco

AU - Capizzi, Silvio

AU - Capri, S

AU - Gualano,

AU - Nicolotti, N

AU - Kheiraoui, F

AU - Sferrazza, A

AU - Mancuso, Agostino

AU - Avallone, G

AU - La Torre, G

AU - Ricciardi, Walter

PY - 2013

Y1 - 2013

N2 - Nessuno

AB - Nessuno

KW - Health Technology Assessment

KW - Human-derived Urofollitropin

KW - Infertility

KW - Health Technology Assessment

KW - Human-derived Urofollitropin

KW - Infertility

UR - http://hdl.handle.net/10807/51118

M3 - Conference contribution

SN - Nessuno

SP - 107

BT - Proceedings of 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”

T2 - 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”

Y2 - 15 June 2013 through 19 June 2013

ER -

Health technology assessment of fostimon, a highly purified human-derived urofollitropin for the treatment of infertility

Abstract

Convegno

OSS delle Nazioni Unite

Keywords

Altri file e collegamenti

Fingerprint

Cita questo